Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study-Reference-Cited by-同舟云学术

Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study

Published:2011-09-28 Issue:3 Volume:21 Page:314-319
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Moulis Guillaume¹,Sailler Laurent¹,Sommet Agnès¹,Lapeyre-Mestre Maryse¹,Montastruc Jean-Louis¹,

Affiliation:

1. U1027 INSERM Pharmacoepidemiology Unit, Department of Clinical Pharmacology Centre Régional Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur les Médicaments, Toulouse University Hospital; University of Toulouse; Toulouse; France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference22 articles.

1. Food and Drug Administration Dear doctor letter important drug warning - potential risk of acute renal failure reported to be associated with administration of immune globulin intravenous (human) 1999 http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105901.htm

2. Acute renal failure due to immunoglobulins;Peyrade;Rev Med Interne,1998

3. Agence Française de Sécurité Sanitaire des Produits de Santé Risques d'insuffisance rénale liée à l'utilisation d'immunoglobulines intra-veineuses 2006 http://www.afssaps.fr/Infos-de-securite/Lettres-aux-professionnels-de-sante/Risques-d-insuffisance-renale-liee-a-l-utilisation-d-Immunoglobulines-intra-veineuses

4. Imputation of the unexpected or toxic effects of drugs. actualization of the method used in France;Bégaud;Therapie,1985

5. French Pharmacovigilance Database system: examples of utilisation;Moore;Therapie,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury due to sucrose-containing intravenous immunoglobulins;Saudi Journal of Kidney Diseases and Transplantation;2019

2. Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017;Drug Safety;2018-12-10

3. Occurrence of acute renal failure on the same day as immune globulin product administrations during 2008 to 2014;Transfusion;2017-10-12

4. Analysis of Argonaute 2-microRNA complexes in ex vivo stored red blood cells;Transfusion;2017-09-20

5. Agammaglobulinemia: comorbidities and long-term therapeutic risks;Expert Opinion on Orphan Drugs;2017-05-24